Percutaneous Left Atrial Appendage Occlusion for the Prevention of Stroke in Patients with Atrial Fibrillation: Review and Critical Appraisal / 대한뇌졸중학회지
Journal of Stroke
;
: 281-291, 2018.
Article
in English
| WPRIM
| ID: wpr-716868
ABSTRACT
The authors review the current status of percutaneous left atrial appendage (LAA) occlusion therapy in patients with atrial fibrillation with the goal to prevent ischemic stroke and systemic embolism and to reduce oral anticoagulation associated bleeding. While we cover the historical and also surgical background, and all tested devices, the main focus rests on the single currently U.S. Food and Drug Administration (FDA) approved LAA occluder, the WATCHMAN device, and its approval process. The authors also give a critical appraisal beyond the review of mere facts, trying to put the current data into perspective.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Atrial Fibrillation
/
United States Food and Drug Administration
/
Brain Ischemia
/
Atrial Appendage
/
Stroke
/
Intracranial Hemorrhages
/
Embolism
/
Hemorrhage
Limits:
Humans
Language:
English
Journal:
Journal of Stroke
Year:
2018
Type:
Article
Similar
MEDLINE
...
LILACS
LIS